InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,284.00
(
0.36%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.31
(
0.99%
)
Bitcoin
61,425.78
(
1.03%
)
Post# of 252405
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119941
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 08/05/2004 9:38:51 AM

Thursday, August 05, 2004 9:38:51 AM

Post# of 252405
[GTCB] U.S. ATryn program close to being restarted:

http://biz.yahoo.com/bw/040805/55183_1.html

It’s a good sign when a specific time period is given (next three months):

>>
GTC is continuing discussions with the Food and Drug Administration (FDA) regarding a clinical protocol for ATryn® in the United States in the HD indication. Following these discussions, GTC plans to submit an amended Investigational New Drug (IND) application during the next three months. An IND had been previously filed to include US patients in the clinical trials that were submitted to the EMEA.
<<

GTCB CC today at 10 a.m. ET.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up